Kymera Therapeutics, Inc. (NASDAQ:KYMR) Q3 2025 Earnings Call Transcript November 4, 2025
Kymera Therapeutics, Inc. misses on earnings expectations. Reported EPS is $-0.94129 EPS, expectations were $-0.72.
Operator: Good day, everyone. My name is Sophie, and I will be your conference operator today. At this time, I would like to welcome you to the Kymera Therapeutics Third Quarter 2025 Results Call. [Operator Instructions] At this time, I would like to turn the call over to Justine...
